CDC advisers delay vote on restricting infant hepatitis B vaccinations in tense meeting

From 1990 to 2019, reported cases of acute hepatitis B among kids declined by 99% due to infant immunization

After a contentious meeting, vaccine advisers for the US Centers for Disease Control and Prevention (CDC) voted on Thursday to delay a vote on restricting hepatitis B vaccination for infants.

The meeting of the advisory committee on immunization practices (ACIP) turned confrontational at times before one member introduced a motion to delay the vote, which passed by six to three, to give advisers time to examine the wording before taking a vote.